These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8823798)

  • 1. DaunoXome data presented at international cancer meeting.
    Oncology (Williston Park); 1996 Jun; 10(6):830. PubMed ID: 8823798
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS; Wernz J; Scadden DT; Cohen P; Mukwaya GM; von Roenn JH; Jacobs M; Kempin S; Silverberg I; Gonzales G; Rarick MU; Myers AM; Shepherd F; Sawka C; Pike MC; Ross ME
    J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50-1. PubMed ID: 11363534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma: DaunoXome approved.
    AIDS Treat News; 1996 May; (no 246):3-4. PubMed ID: 11363485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DaunoXome approved.
    AIDS Patient Care STDS; 1996 Aug; 10(4):263. PubMed ID: 11361607
    [No Abstract]   [Full Text] [Related]  

  • 6. Liposomal KS drugs approved.
    GMHC Treat Issues; 1996 Apr; 10(4):8-9. PubMed ID: 11363710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel for treating KS.
    Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
    Prescrire Int; 1998 Jun; 7(35):69-70. PubMed ID: 10342919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal chemotherapies.
    Smart T
    GMHC Treat Issues; 1995; 9(7/8):13. PubMed ID: 11362653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal daunorubicin is not recommended in patients with less than advanced HIV-related Kaposi's sarcoma.
    White RM
    AIDS; 1997 Sep; 11(11):1412-3. PubMed ID: 9302461
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma.
    Hjortsberg C; Persson U; Lidbrink E; Bennett C
    Acta Oncol; 1999; 38(8):1063-7. PubMed ID: 10665764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma.
    Fumagalli L; Zucchetti M; Parisi I; Viganò MG; Zecca B; Careddu A; D'Incalci M; Lazzarin A
    Cancer Chemother Pharmacol; 2000; 45(6):495-501. PubMed ID: 10854138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DaunoXome offers KS treatment alternative.
    AIDS Alert; 1996 Jun; 11(6):67-8. PubMed ID: 11363544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal drug targeting in the treatment of Kaposi's sarcoma.
    Wernz JC
    AIDS Patient Care STDS; 1996 Dec; 10(6):362-7. PubMed ID: 11361553
    [No Abstract]   [Full Text] [Related]  

  • 15. KS treatment inches forward.
    Vazquez E
    Posit Aware; 1996; 7(5):9. PubMed ID: 11363790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment for KS offers options for therapy.
    AIDS Alert; 1996 Feb; 11(2):21-2. PubMed ID: 11363236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing combination chemotherapy for Kaposi's sarcoma.
    Yarchoan R; Little R
    Cancer J Sci Am; 1997; 3(5):268-70. PubMed ID: 9327148
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and tolerance of liposomal daunorubicin in Kaposi sarcoma associated with human immunodeficiency virus infection.
    Fournier S; Dupont B; Pialoux G; Eliaszewicz M; Gonzalez-Canali G; Feuillie V
    Arch Dermatol; 1997 Jul; 133(7):918-9. PubMed ID: 9236538
    [No Abstract]   [Full Text] [Related]  

  • 19. Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma.
    Presant CA; Scolaro M; Kennedy P; Blayney DW; Flanagan B; Lisak J; Presant J
    Lancet; 1993 May; 341(8855):1242-3. PubMed ID: 8098393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary Kaposi's sarcoma in a heterosexual parenteral drug addict patient with the acquired immunodeficiency syndrome].
    Grocín AI; Goya MA; Arrizabalaga J; Iribarren JA; Rodríguez-Arrondo F; Tuneu A; Lobo C
    Med Clin (Barc); 1991 Oct; 97(13):500-2. PubMed ID: 1721989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.